POSTDOCTORAL RESEARCHER - EPIGENETIC CONTROL OF HAEMATOPOIESIS

Reference

PDR_JS_35

Places available

1

Deadline for application

31/05/2021

Requirements

What we need 

Candidates must hold a PhD in Biomedical Sciences (
High level of motivation and interest. 
At least 1 first-author publication in high impact journal. 
- Strong background in Molecular and Celullar Biology. 
Previous experience in genome-wide data analysis (RNA-seq, ATAC-seq…)
Fluent in English.  
 
 
 
Main Responsibilities 
 
Selected candidate will design, perform and analyze experiments to develop his/her own research project. 
Selected candidate will apply to competitive postdoc calls (Spain/Europe).  
 
 
 
What we offer 
 
Temporary position starting in Fall 2021.  
Salary offered will be commensurate with candidate’s expertise and publication record.
Working in the mixed basic and clinical research environment of the IJC. 

Additional Information

Research Description 

The team of José Luis Sardina at the Josep Carreras Leukaemia Research Institute is looking for a highly motivated Junior Postdoctoral Researcher.

Epigenetic Control of Haematopoiesis Group is working to uncover the molecular mechanisms governing blood cell fate decisions, with a special interest in those leading to the onset and development of myeloid malignancies. To address this goal, they are combining transcriptome (by RNA-seq) and epigenome profiling (by WG(ox)BS-seq, ATAC-seq and ChIP-seq for histone marks) of primary blood samples with in-depth molecular studies (by CRISPR/Cas9 (epi)genome editing) in unique models of experimentally induced blood cell fate conversions. 

For more information  

Publications. https://scholar.google.es/citations?user=oxMYLc8AAAAJ&hl=es 

Research lines. http://www.carrerasresearch.org/en/epigenetic-control-of-haematopoiesis_129594 

 

Who we are? 

Our mission is to carry out research into the basic, epidemiological, preventive, clinical and translational aspects of leukemia and other hematologic malignancies. 

The vision of the Josep Carreras Leukaemia Research Institute is that research will identify new therapeutic targets and enable us to develop more precise and less aggressive treatments.  We aspire to understand the origin and development of leukemias and other malignant hematological pathologies in order to be able to prevent them.  We will work for a future in which all leukemias will be curable. 

For further information, please, visit our webpage: http://www.carrerasresearch.org/en and the Josep Carreras nonprofit organizationhttps://www.fcarreras.org/en. 

The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles. 

The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies- 

This EC initiative aims to promote training, professional development, and mobility for all European scientists.  The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research and firmly situate the organization as an institution with a stimulating working environment that favors the development of its scientists. 

IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, and other legally protected characteristics. 

Place of presentation of the candidacies

How to apply 

To apply for this opportunity, please send your CV and cover letter (including the contact details of two referees) to Dr. José Luis Sardina jobs@carrerasresearch.org. Please, include in the subject the reference REF.: PDR_JS_35. 

 

Deadline for Applications 

Please submit your application by May 31, 2021. 

Related links